Journal Club #13 – Daan Keiman (MA): “Psychedelic chaplaincy: integrating interfaith spiritual care into psychedelic therapies and science”

Our 13th JC instalment will be hosted by Daan Keiman (MA). The title is “Psychedelic Chaplaincy – Integrating Interfaith Spiritual Care Into Psychedelic Therapies and Science”. See below for more details Where: Vrije Universiteit Amsterdam, Mathematics and Science (WN) Building, Room M129 When: Friday, November 29th, 5pm (presentation will start ~5.15pm) RSVP: Facebook Event Entrance is free for registered […]

Journal Club #12 – Aidan Lyon (PhD): “Attention: A Unified Theory of Psychedelics and Meditation”

Our 12th JC instalment will be hosted by Aidan Lyon (PhD). The title is “Attention: A Unified Theory of Psychedelics and Meditation”. See below for more details Where: Vrije Universiteit Amsterdam, Mathematics and Science (WN) Building, Room M129 When: Friday, October 18th, 5pm (presentation will start ~5.15pm) RSVP: Facebook Event Entrance is free for registered APRA members who have […]

Interview with Dr. Rudolf Faust

Isolde de Jong started her internship with APRA in November 2018, ever since she is reporting activities within the organization. As a student of applied psychology with a main interest in psychedelic research, she developed a strong curiosity in the biological mechanisms of certain entheogenic plants and other substances. With this internship she hopes to […]

New realities in psychotrauma

Journal Club #11 – Koen Seignette (PhD cand.): “Feedback-feedforward information processing unbalances and the neurophysiology of hallucinations”

Our 11th JC installment will be hosted by Koen Seignette, PhD student at the Netherlands Institute for Neuroscience. Koen’s work focuses on sensory processing and plasticity, perceptual learning, feedforward and feedback integration in mouse V1, in the Christiaan Levelt Lab. Where: Vrije Universiteit Amsterdam, Medical Faculty Building, Room D565 When: Tuesday, May 21st, 6pm (presentation […]

Opening Up [Symposium] – Shaping the future: therapeutic applications of MDMA

This symposium discusses research into the therapeutic use of MDMA, both historically and presently.

Considerations on Esketamine for Depression

Considerations on Esketamine for Depression by Ivar Rambags, Marco Aqil, and Jennifer Them Back in 1956, ketamine was originally derived from phencyclidine as a shorter acting analogue with less delirious side effects [1]. By then still known as CI-581, ketamine’s first clinical results were published by Corssen and Domino in 1966 and revealed itself to […]